Edition:
United Kingdom

Kalvista Pharmaceuticals Inc (KALV.OQ)

KALV.OQ on NASDAQ Stock Exchange Global Market

16.66USD
21 Aug 2018
Change (% chg)

$1.82 (+12.26%)
Prev Close
$14.84
Open
$15.27
Day's High
$16.85
Day's Low
$15.02
Volume
27,043
Avg. Vol
5,684
52-wk High
$16.85
52-wk Low
$5.48

Chart for

About

KalVista Pharmaceuticals, Inc., formerly Carbylan Therapeutics, Inc., is a clinical-stage pharmaceutical company. The Company is focused on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The Company has developed a portfolio of small molecule plasma kallikrein... (more)

Overall

Beta: 2.62
Market Cap(Mil.): $164.15
Shares Outstanding(Mil.): 12.58
Dividend: --
Yield (%): --

Financials

  KALV.OQ Industry Sector
P/E (TTM): -- 28.28 30.39
EPS (TTM): -1.55 -- --
ROI: -45.48 12.94 12.61
ROE: -53.96 14.96 14.80

Earnings vs. Estimates